Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

Therapeutics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Mutation Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Protein-Tyrosine Kinases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2011 2017

Cancer immunotherapy in older patients

Marrone, K. A. & Forde, P. M. Jul 1 2017 In : Cancer Journal (United States). 23, 4, p. 219-222 4 p.

Research output: Research - peer-reviewReview article

Immunotherapy
Neoplasms
Immune System
Explosions
Clinical Trials

Evolution of neoantigen landscape during immune checkpoint blockade in non-small cell lung cancer

Anagnostou, V. , Smith, K. N. , Forde, P. M. , Niknafs, N. , Bhattacharya, R. , White, J. , Zhang, T. , Adleff, V. , Phallen, J. , Wali, N. , Hruban, C. , Guthrie, V. B. , Rodgers, K. , Naidoo, J. , Kang, H. , Sharfman, W. , Georgiades, C. , Verde, F. , Illei, P. , Li, Q. K. & 9 others Gabrielson, E., Brock, M. V., Zahnow, C. A., Baylin, S. B., Scharpf, R. B., Brahmer, J. R., Karchin, R., Pardoll, D. M. & Velculescu, V. E. Mar 1 2017 In : Cancer Discovery. 7, 3, p. 264-276 13 p.

Research output: Research - peer-reviewArticle

Non-Small Cell Lung Carcinoma
Neoplasms
T-Lymphocytes
Mutation
Therapeutics

Immuno-oncology clinical trial design: Limitations, challenges, and opportunities

Baik, C. S., Rubin, E. H., Forde, P. M., Mehnert, J. M., Collyar, D., Butler, M. O., Dixon, E. L. & Chow, L. Q. M. Sep 1 2017 In : Clinical Cancer Research. 23, 17, p. 4992-5002 11 p.

Research output: Research - peer-reviewArticle

Clinical Trials
Therapeutics
Neoplasms
Safety
Virus Diseases

Immuno-oncology trial endpoints: Capturing clinically meaningful activity

Anagnostou, V., Yarchoan, M., Hansen, A. R., Wang, H., Verde, F., Sharon, E., Collyar, D., Chow, L. Q. M. & Forde, P. M. Sep 1 2017 In : Clinical Cancer Research. 23, 17, p. 4959-4969 11 p.

Research output: Research - peer-reviewArticle

Clinical Trials
Biomarkers
Therapeutics
Survival Rate
Drug Therapy

Inflammatory arthritis: A newly recognized adverse event of immune checkpoint blockade

Naidoo, J., Cappelli, L. C., Forde, P. M., Marrone, K. A., Lipson, E. J., Hammers, H. J., Sharfman, W. H., Le, D. T., Baer, A. N., Shah, A. A., Albayda, J., Manno, R. L., Haque, U., Gutierrez, A. K., Bingham, C. O. & Brahmer, J. R. Jun 1 2017 In : Oncologist. 22, 6, p. 627-630 4 p.

Research output: Research - peer-reviewComment/debate